Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy-Reference-Cited by-同舟云学术

Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy

Published:2017-08-22 Issue:22 Volume:23 Page:6946-6957
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kong Yan,Sheng Xinan,Wu Xiaowen,Yan Junya,Ma Meng,Yu Jiayi,Si Lu,Chi Zhihong,Cui Chuanliang,Dai Jie,Li Yiqian,Yu Huan,Xu Tianxiao,Tang Huan,Tang Bixia,Mao Lili,Lian Bin,Wang Xuan,Yan Xieqiao,Li Siming,Guo Jun

Funder

Major State Basic Research Development Program of China

National Natural Science Foundation of China

Beijing Municipal Natural Science Foundation

Beijing Baiqianwan Talents Project, Beijing Municipal Administration of Hospitals Clinical medicine Development

Beijing Municipal Science & Technology Commission

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling;International Journal of Cancer;2024-07-12

2. Novel liquid biopsy CNV biomarkers in malignant melanoma;Scientific Reports;2024-07-09

3. Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment;2024-06-17

4. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma;Holistic Integrative Oncology;2024-05-28

5. Single-cell RNA sequencing unveils tumor heterogeneity and immune microenvironment between subungual and plantar melanoma;Scientific Reports;2024-03-25